Publication | Open Access
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
26
Citations
33
References
2012
Year
PP-LAI appears to be a cost-effective option for treating chronic schizophrenia in Greece compared with RIS-LAI since it results in savings to the health care system along with better patient outcomes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1